| Predictors of heart failure in patients with stable coronary artery disease: a PEACE study. | |
| | |
MedLine Citation:
|
PMID: 19808342 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Heart failure (HF) is a disease commonly associated with coronary artery disease. Most risk models for HF development have focused on patients with acute myocardial infarction. The Prevention of Events with Angiotensin-Converting Enzyme Inhibition population enabled the development of a risk model to predict HF in patients with stable coronary artery disease and preserved ejection fraction. METHODS AND RESULTS: In the 8290, Prevention of Events with Angiotensin-Converting Enzyme Inhibition patients without preexisting HF, new-onset HF hospitalizations, and fatal HF were assessed over a median follow-up of 4.8 years. Covariates were evaluated and maintained in the Cox regression multivariable model using backward selection if P<0.05. A risk score was developed and converted to an integer-based scoring system. Among the Prevention of Events with Angiotensin-Converting Enzyme Inhibition population (age, 64+/-8; female, 18%; prior myocardial infarction, 55%), there were 268 cases of fatal and nonfatal HF. Twelve characteristics were associated with increased risk of HF along with several baseline medications, including older age, history of hypertension, and diabetes. Randomization to trandolapril independently reduced the risk of HF. There was no interaction between trandolapril treatment and other risk factors for HF. The risk score (range, 0 to 21) demonstrated excellent discriminatory power (c-statistic 0.80). Risk of HF ranged from 1.75% in patients with a risk score of 0% to 33% in patients with risk score >or=16. CONCLUSIONS: Among patients with stable coronary artery disease and preserved ejection fraction, traditional and newer factors were independently associated with increased risk of HF. Trandolopril decreased the risk of HF in these patients with preserved ejection fraction. |
| | |
Authors:
|
Eldrin F Lewis; Scott D Solomon; Kathleen A Jablonski; Madeline Murguia Rice; Francesco Clemenza; Judith Hsia; Aldo P Maggioni; Miguel Zabalgoitia; Thao Huynh; Thomas E Cuddy; Bernard J Gersh; Jean Rouleau; Eugene Braunwald; Marc A Pfeffer; |
Publication Detail:
|
Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't Date: 2009-04-14 |
Journal Detail:
|
Title: Circulation. Heart failure Volume: 2 ISSN: 1941-3297 ISO Abbreviation: Circ Heart Fail Publication Date: 2009 May |
Date Detail:
|
Created Date: 2009-10-07 Completed Date: 2009-10-27 Revised Date: 2010-12-28 |
Medline Journal Info:
|
Nlm Unique ID: 101479941 Medline TA: Circ Heart Fail Country: United States |
Other Details:
|
Languages: eng Pagination: 209-16 Citation Subset: IM |
Affiliation:
|
Cardiovascular Division, Brigham and Women's Hospital, Boston, Mass 02115, USA. eflewis@partners.org |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Angiotensin-Converting Enzyme Inhibitors / therapeutic use* Coronary Artery Disease / complications*, drug therapy, mortality, physiopathology Female Heart Failure / etiology*, mortality, physiopathology, prevention & control Humans Indoles / therapeutic use* Kaplan-Meier Estimate Male Middle Aged Predictive Value of Tests Proportional Hazards Models Risk Assessment Risk Factors Stroke Volume / drug effects Time Factors Treatment Outcome Ventricular Function, Left / drug effects |
| Grant Support | |
ID/Acronym/Agency:
|
N01 HC065149-00/HC/NHLBI NIH HHS; N01 HC65149/HC/NHLBI NIH HHS; N01HC065149/HC/NHLBI NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Angiotensin-Converting Enzyme Inhibitors; 0/Indoles; 87679-37-6/trandolapril |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Adiposity and incidence of heart failure hospitalization and mortality: a population-based prospecti...
Next Document: Leukocyte count and incidence of hospitalizations due to heart failure.